Tencent Delivers Double-Digit Growth in Profit, Revenue
The videogame and social-media company extended its recent streak of earnings beats amid continued AI integration efforts and strong momentum at its gaming business.
—-
How a Chinese AI Company Worked Around U.S. Rules to Access Nvidia’s Top Chips
In Indonesia, semiconductors covered by U.S. export controls are ready to help a Shanghai-based group.
—-
Rio Tinto to Shelve $2.4 Billion Serbian Lithium Project
The miner has faced repeated setbacks advancing the project amid community opposition.
—-
Siemens Revenue Rises, But Net Profit Falls
The industrial conglomerate targets comparable revenue growth in the range of 6% to 8% for fiscal 2026.
—-
Hapag-Lloyd Narrows Guidance Further as Higher Demand Counters Falling Freight Rates
The world’s fifth-largest container line by capacity expects current trends to continue through to year-end, with increasing volumes and falling freight rates.
—-
Germany’s Merck Posts Higher Earnings on Organic Growth Across Units
Merck KGaA’s sales grew 5.2%, driven by demand for pharma-production products, rare diseases treatments and semiconductor materials in its electronics unit.
—-
Cisco Systems Boosts Outlook on AI-Driven Demand
CEO Chuck Robbins said the networking-equipment company is on track for its strongest year yet.
—-
Biomining Startup Gets $13.5 Million as Critical Minerals Race Gathers Speed
Endolith closed an initial tranche of a Series A round led by national security-focused venture-capital firm Squadra Ventures, and expects to raise $3 million more shortly.
—-
Packaging Company Sealed Air in Talks to Go Private
Private-equity firm Clayton Dubilier & Rice discussing deal for company.
—-
Proxy Advisers ISS and Glass Lewis Are Facing Antitrust Probes
An FTC investigation is focused on how proxy advisers steer investors on climate and ESG issues.
—-
FanDuel Follows DraftKings Into Prediction Markets
The sports betting firm said Wednesday that it will debut a stand-alone prediction market app called FanDuel Predicts, in partnership with CME Group.
—-
First New Malaria Drug in Years Performs Strongly in Late-Stage Testing
Novartis said its experimental treatment cured more than 99% of malaria cases in the trial, marking a big step toward approval.
—-
JD.com Profit Plunged. Why the Stock Is Rising.
JD.com and its rivals Alibaba Group Holding and Meituan have been locked in an e-commerce price war.
—-
Disney Earnings Are Coming. 3 Things to Watch.
Streaming is likely to be a major focus. Here’s what else the market should keep an eye on.
(END) Dow Jones Newswires
November 13, 2025 05:15 ET (10:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.